SCHEMBL4097250

SCHEMBL4097250

COCOc1cc(OC)ccc1C(=O)N(C)OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.50
CYP3A4 P08684 2/20 0.48
TSHR P16473 2/20 0.48
CYP2C19 P33261 2/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
ALDH1A1 P00352 1/20 0.48
CLK1 P49759 1/20 0.47
DYRK1A Q13627 1/20 0.47
DYRK1B Q9Y463 1/20 0.47
BACE1 P56817 1/20 0.46
POLB P06746 1/20 0.45
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
LMNA P02545 2/20 0.44
CYP1A2 P05177 1/20 0.44
NPC1 O15118 1/20 0.43
ABCG2 Q9UNQ0 2/20 0.43
USP2 O75604 1/20 0.42
MAPK1 P28482 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4109938 0.90 MAPT (0.53) MAPTCYP3A4TSHRCYP2C19CYP2D6
SCHEMBL4841763 0.86 NPC1 (0.57) MAPTCYP3A4TSHRCYP2C19ALDH1A1
SCHEMBL17100247 0.84 FFAR4 (0.40) MAPTCYP3A4TSHRCYP2C19CYP2D6
SCHEMBL4210042 0.81 KDM4E (0.43) CYP2C19CYP2C9ALDH1A1KMT2ACYP1A2
SCHEMBL4103072 0.80 MAPT (0.52) MAPTCYP3A4TSHRCYP2C19CYP2D6
SCHEMBL4215199 0.80 ALDH1A1 (0.57) MAPTCYP3A4TSHRCYP2C19CYP2D6
SCHEMBL4304248 0.79 MAPT (0.51) MAPTCYP3A4TSHRCYP2C19CYP2D6
SCHEMBL4102432 0.78 CYP3A4 (0.40) MAPTCYP3A4TSHRCYP2C19CYP2D6
SCHEMBL31432461 0.78 BACE1 (0.52) MAPTCYP3A4TSHRCYP2C19CYP2D6
SCHEMBL12857970 0.77 HTT (0.53) MAPTCYP3A4TSHRCYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090054435-A1 Phenoxyalkanoic Acid Compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-02-26 US disclosed
EP-1911738-A1 PHENOXYALKANOIC ACID COMPOUND Takeda Pharmaceutical Company Limited (JP) 2008-04-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054435-A1 Phenoxyalkanoic Acid Compound PNLIP, GPR119, LIPC MAPT 3533/4885CYP3A4 708/4885TSHR 2460/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.